Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories, 64159 [2018-27029]
Download as PDF
<![CDATA[
64159
Federal Register / Vol. 83, No. 239 / Thursday, December 13, 2018 / Notices
Dated: December 3, 2018.
John J. Martin,
Assistant Administrator.
Cocaine .........................
Codeine .........................
Dihydrocodeine ..............
Oxycodone ....................
Hydromorphone .............
Ecgonine ........................
Hydrocodone .................
Morphine ........................
Thebaine ........................
[FR Doc. 2018–27036 Filed 12–12–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Eli-Elsohly
Laboratories
ACTION:
Drug
code
Controlled substance
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 22, 2017, Eli-Elsohly
Laboratories, Mahmoud A. Elsohly
Ph.D., 5 Industrial Park Drive, Oxford,
Mississippi 38655 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
9041
9050
9120
9143
9150
9180
9193
9300
9333
Schedule
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for
product development and reference
standards. In reference to drug codes
7360 (marihuana) and 7370 (THC), the
company plans to isolate these
controlled substances from procured
7350 (marihuana extract). In reference to
drug code 7360 (marihuana), no
cultivation activities are authorized for
this registration. No other activities for
these drug codes are authorized for this
registration.
Dated: December 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–27029 Filed 12–12–18; 8:45 am]
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 16,
2018, Cambrex High Point Inc., 4180
Mendenhall Oaks Parkway, High Point,
North Carolina 27265 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Controlled
substances
Oxymorphone ................
Noroxymorphone ...........
Drug
code
9652
9668
Schedule
II
II
The company plans to manufacture
the above listed controlled substances in
bulk for distribution to its customers.
Dated: December 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–27039 Filed 12–12–18; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
amozie on DSK3GDR082PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
Controlled substance
Marihuana Extract .........
Marihuana ......................
Tetrahydrocannabinols ..
Dihydromorphine ...........
Amphetamine ................
Methamphetamine .........
VerDate Sep<11>2014
Drug
code
7350
7360
7370
9145
1100
1105
17:12 Dec 12, 2018
Schedule
I
I
I
I
II
II
Jkt 247001
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cambrex
High Point, Inc.
ACTION:
Notice of application.
Frm 00063
Fmt 4703
Sfmt 4703
Importer of Controlled Substances
Application: Noramco Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 14, 2019. Such
persons may also file a written request
for a hearing on the application on or
before January 14, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
DATES:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 11, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
DATES:
PO 00000
Drug Enforcement Administration
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 83, Number 239 (Thursday, December 13, 2018)]
[Notices]
[Page 64159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27029]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Eli-
Elsohly Laboratories
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before February 11, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 22, 2017, Eli-Elsohly Laboratories, Mahmoud A. Elsohly Ph.D.,
5 Industrial Park Drive, Oxford, Mississippi 38655 applied to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Cocaine................................ 9041 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Ecgonine............................... 9180 II
Hydrocodone............................ 9193 II
Morphine............................... 9300 II
Thebaine............................... 9333 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for product development and reference standards. In reference to drug
codes 7360 (marihuana) and 7370 (THC), the company plans to isolate
these controlled substances from procured 7350 (marihuana extract). In
reference to drug code 7360 (marihuana), no cultivation activities are
authorized for this registration. No other activities for these drug
codes are authorized for this registration.
Dated: December 3, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-27029 Filed 12-12-18; 8:45 am]
BILLING CODE 4410-09-P
